drug
ARCT-810
Phase 2updated 3mo agoby $ARCT Arcturus Therapeutics Holdings Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ARCT-810
- phase2Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810
- phase2A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
- phase1Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency
- phase1Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that